Similar articles

• Anti-tumor necrosis factor therapy and Listeria monocytogenes infection: report of two cases.

  Glück T, Linde HJ, Schölmerich J, Müller-Ladner U, Fiehn C, Bohland P. Glück T, et al. Arthritis Rheum. 2002 Aug;46(8):2255-7; author reply 2257. doi: 10.1002/art.10374. Arthritis Rheum. 2002. PMID: 12209538 No abstract available.
• The increasing prevalence of listeriosis--what are we missing?

  Khatamzas E, Hughes H, Grant KA, McLauchlin J, Bowler IC. Khatamzas E, et al. QJM. 2010 Jul;103(7):519-22. doi: 10.1093/qjmed/hcp181. Epub 2009 Dec 30. QJM. 2010. PMID: 20042433 No abstract available.
• Listeria monocytogenes joint infection in a patient with psoriatic arthritis.

  Marangos MN, Keroack BJ, Claffey TF. Marangos MN, et al. J Rheumatol. 1996 Nov;23(11):2005-6. J Rheumatol. 1996. PMID: 8923390 Review. No abstract available.
• Successful rechallenge with anti-tumor necrosis factor alpha for psoriatic arthritis after development of demyelinating nervous system disease during initial treatment: comment on the article by Mohan et al.

  Cisternas M, Gutiérrez M, Jacobelli S. Cisternas M, et al. Arthritis Rheum. 2002 Nov;46(11):3107-8; author reply 3108-9. doi: 10.1002/art.10488. Arthritis Rheum. 2002. PMID: 12428265 No abstract available.
• Guideline for anti-TNF-alpha therapy in psoriatic arthritis.

  Kyle S, Chandler D, Griffiths CE, Helliwell P, Lewis J, McInnes I, Oliver S, Symmons D, McHugh N; British Society for Rheumatology Standards Guidelines Audit Working Group (SGAWG). Kyle S, et al. Rheumatology (Oxford). 2005 Mar;44(3):390-7. doi: 10.1093/rheumatology/keh514. Epub 2005 Feb 3. Rheumatology (Oxford). 2005. PMID: 15695305 Review. No abstract available.